Global Hospital press release: 60 YEAR OLD FEMALE CANCER SURVIVOR UNDERWENT SUCCESSFUL BREAST CONSERVATION SURGERY

Global Hospital press release: 60 YEAR OLD FEMALE CANCER SURVIVOR UNDERWENT SUCCESSFUL BREAST CONSERVATION SURGERY

60 YEAR OLD FEMALE CANCER SURVIVOR UNDERWENT SUCCESSFUL BREAST CONSERVATION SURGERY

Chennai, December 5th 2019: A 60-year-old female cancer survivor from Baharain who had previously treated for endometrial cancer has successfully undergone breast conservation surgery at Gleneagles Global Health City, the largest facility of Gleneagles Global Hospitals, Chennai. During her recent follow up’s, Doctors at Gleneagles Global Health City detected a small hypoechoic lesion of size 1 X 0.8 cm in upper outer quadrant of her left breast during a mammogram. She did not have any symptoms and a thorough clinical examination did not reveal any breast lump or palpable axillary nodes.

The patient underwent ultrasound-guided core needle biopsy which was suggestive of Invasive lobular carcinoma. Metastatic workup did not reveal any spread of cancer elsewhere in her body. She underwent pre-operative localisation of the lesion with J WIRE under image guidance. Following which she underwent breast conservation surgery, i.e Wide Local Excision under J WIRE Guidance. The patient also underwent Sentinel Lymph Node biopsy to accurately assess the spread of a tumour to the axillary lymph node & thereby avoiding unnecessary axillary nodal dissection 

Detection of breast cancer at a very early stage not only makes it easily curable but also offers best cosmetic result, said Dr Rajasundaram, Director, Institute of Oncology, Gleneagles Global Health City. The sentinel lymph node biopsy technique significantly reduces the rate of unnecessary axillary lymphadenectomy thereby avoiding complications such as lymphedema, shoulder dysfunction, loss of sensation overarm & seroma formation said, Dr Raja Sundaram

Full field Digital Mammogram (FFDM) is essential in the treatment of very early breast cancer, it can detect non-palpable lesions and has risk stratification of newly detected lesions based on BI-RADS criteria said, Dr Rajasu ndaram. 

About Gleneagles Global Health City, Chennai:

Gleneagles Global Health City, the sprawling 21-acre facility located in Perumbakkam, Chennai is the largest facility of Gleneagles Global Hospitals India. With a capacity of over 1000 beds and accreditations from leading agencies, the facility is Asia’s most trusted and leading Multi-Organ Transplant Centre. The hospital has undertaken several path-breakingLiver, Neuro, Heart, Lung and Kidney procedures. It is recognized by several international and national level accrediting agencies. World-class infrastructure, dedicated staff and a commitment for medical excellence are the USPs of this facility. The hospital has several achievements to its credit and continues to work on several pioneering procedures.

Gleneagles Global Hospitals has multi-super speciality hospitals in Bengaluru, Hyderabad, Chennai and Mumbai. The brand is the most preferred hospital group for multi-organ transplants in Asia region. The parent entity of Gleneagles Global Hospitals is IHH Healthcare, a leading premium integrated healthcare provider with a network of 84 hospitals and more than 16,000 licensed beds. It is one of the largest healthcare groups in the world by market capitalisation and is listed in the Main Market of Bursa Malaysia and Main Board of SGX-ST. IHH is a leading player in the home markets of Malaysia, Singapore, Turkey and India, and in their key growth markets of China and Hong Kong. 

Website: http://gleneaglesglobalhospitals.com/